기사

2006년 8월 17일

Daniel Rosan, Program Director for Public Health, Interfaith Center on Corporate Responsibility [USA]

International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

[Presentation by Daniel Rosan begins at 54:30; refers to Abbott Laboratories, Bristol-Myers Squibb, Merck, Gilead Sciences, Wyeth]

타임라인

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

날짜:

2014년 3월 4일

내용 유형:

기업 응답

이용 가능한 언어: English
[PDF] Benchmarking AIDS: 2006 Year End Update

날짜:

2006년 11월 30일

내용 유형:

기사

이용 가능한 언어: English
Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.

날짜:

2006년 9월 13일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.

날짜:

2006년 9월 13일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

날짜:

2006년 9월 13일

내용 유형:

기업 응답

이용 가능한 언어: English
Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

날짜:

2006년 9월 12일

내용 유형:

기사

이용 가능한 언어: English
Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.

날짜:

2006년 9월 6일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

날짜:

2006년 9월 6일

내용 유형:

기업 응답

이용 가능한 언어: English
Reclaman mayor compromiso de las farmacéuticas

날짜:

2006년 8월 31일

내용 유형:

기사

이용 가능한 언어: español
Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.

날짜:

2006년 8월 23일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.

날짜:

2006년 8월 23일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.

날짜:

2006년 8월 23일

내용 유형:

기업 응답

이용 가능한 언어: English
International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

날짜:

2006년 8월 17일

내용 유형:

기사

이용 가능한 언어: English
[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"

날짜:

2006년 8월 17일

내용 유형:

기사

이용 가능한 언어: English
New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

날짜:

2006년 8월 14일

내용 유형:

기사

이용 가능한 언어: English
Sanofi-Aventis did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including sanofi-aventis - finds none has comprehensive approach.

날짜:

2006년 8월 1일

내용 유형:

기업 응답

이용 가능한 언어: English
Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

날짜:

2006년 8월 1일

내용 유형:

기업 응답

이용 가능한 언어: English
Hoffmann-La Roche (part of Roche) did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Hoffman-La Roche - finds none has comprehensive approach.

날짜:

2006년 1월 8일

내용 유형:

기업 응답

이용 가능한 언어: English
Gilead Sciences did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Gilead - finds none has comprehensive approach.

날짜:

2006년 1월 8일

내용 유형:

기업 응답

이용 가능한 언어: English

전체 스토리 보기

더 보기 덜 보기

Business & Human Rights
Resource Centre

구속력 있는 조약

실사 의무화

공동번영의 모색: 정의로운 전환을 위한 원주민 리더십과 파트너십

Switched off: 테크기업의 투명성 부족과 가자지구에서의 이스라엘-하마스 전쟁

기업과인권리소스센터

구속력 있는 조약

실사 의무화

공동번영의 모색: 정의로운 전환을 위한 원주민 리더십과 파트너십

Switched off: 테크기업의 투명성 부족과 가자지구에서의 이스라엘-하마스 전쟁

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

타임라인

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

[PDF] Benchmarking AIDS: 2006 Year End Update

Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.

Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.

Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.

Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

Reclaman mayor compromiso de las farmacéuticas

Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.

Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.

Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.

International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

Sanofi-Aventis did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including sanofi-aventis - finds none has comprehensive approach.

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

Hoffmann-La Roche (part of Roche) did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Hoffman-La Roche - finds none has comprehensive approach.

Gilead Sciences did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Gilead - finds none has comprehensive approach.